Synthetic lung cancer study with 500 target and 500 control patients.
Target cohort contains three designed trajectories:
0) Diagnostic pathway (bronchoscopy + lung biopsy + diagnosis)
1) Radiotherapy + chemotherapy
2) Partial lung resection
3) End-of-life / dying pathway
